Skip to main content
. 2019 Jan 15;321(2):156–164. doi: 10.1001/jama.2018.20046

Table 1. Baseline Characteristics of the Study Groups.

Characteristic Donor Fecal Microbiota Transplantation (n = 38) Autologous Fecal Microbiota Transplantation (n = 35)
Sex, No. (%)
Women 18 (47) 15 (43)
Men 20 (53) 20 (57)
Age, median (IQR), y
At diagnosis 30.5 (22-48) 29 (21-39)
At randomization 38.5 (28-52) 35 (25-46)
Duration of disease, median (IQR), y 4.9 (1.6-9.6) 5.8 (2.4-11)
Left-sided disease only, No. (%)a 23 (61) 22 (63)
Total Mayo score, mean (SD)b 7.2 (1.7) 7.4 (1.9)
Medication, No. (%)
Oral steroids 8 (21) 11 (31)
Oral 5-ASA 33 (87) 24 (69)
Topical 5-ASA 11 (29) 7 (20)
Immunomodulatorc 14 (37) 15 (43)
Biologicsd 3 (8) 4 (11)
Inflammatory markers, median (IQR)
CRP, mg/L 2.8 (1.3-7.2) 2.3 (0.8-10)
WBC count, /μL 6200 (5300-7300) 7900 (6100-8900)
Fecal calprotectin, mg/kg 566.5 (372.5-2687.5) 774 (221-1768)
Diet, mean (SD)e
Protein, g 97 (38) 109 (42)
Carbohydrate, g 230 (70) 221 (102)
Total Fat, g 76 (33) 86 (34)
Saturated Fat, g 29 (16) 32 (15)
Sugars, g 90 (36) 103 (74)
Starch, g 139 (56) 115 (54)
Fiber, g 19 (8) 21 (8)
Calcium, mg 700 (467) 718 (447)
Iron, g 11.1 (6.5) 10.8 (4.4)
Energy, kJ 8742 (2574) 9049 (3111)
Sulfate, mg 1768 (2110) 2073 (3191)

Abbreviations: 5-ASA, 5-aminosalicylate; CRP, C-reactive protein; IQR, interquartile range; WBC, white blood cell.

SI conversion factor: To convert CRP to nmol/L, multiply by 9.524.

a

Left-sided disease only defined as disease not extending proximal to the splenic flexure.

b

Total Mayo score is a composite of clinical and endoscopic parameters. It ranges from 0 to 12 (clinical remission ≤2; mild disease, 3-6; moderate disease, 7-10; and severe disease, 11-12).

c

Immunomodulators were either azathioprine or 6-mercaptopurine.

d

Biologics were either infliximab or vedolizumab.

e

Dietary information was acquired via 3-day diet diary conducted prior to patient receiving fecal microbiota transplantation.